InsiderPulseNo transactions found.
| Date | Member | Chamber | Type | Amount |
|---|---|---|---|---|
| 2025-03-25 | George Whitesides(D-CA27) | house | Sale | $250,001 - $500,000 |
No financial data available for INVA.
Company may not file with SEC or CIK is unresolved.
3 Bargain-Cheap Small Caps Worth a Second Look
Beacon Biosignals Upsizes Series B Financing to Over $97 Million
Analysts See This Pharma Stock Surging 60%; Eyes Fresh Entry
Is It Time To Revisit Innoviva (INVA) After Strong Multi Year Share Price Gains
Mutiny At Aurinia Pharmaceuticals? Biotech Rallies On C-Suite Shake-Up
Biohaven Stock Down 70% but One Fund's New $6 Million Bet Signals Turnaround Potential
PJP: Healthcare Dashboard For March
Innoviva Specialty Therapeutics Earns Strong Performance Rating in Access to Medicine Foundation’s 2026 Antimicrobial Resistance Benchmark Report
Cantor Fitzgerald Lifts PT on Innoviva, Inc. (INVA) to $32 from $31 – Here’s Why
Innoviva, Inc. (INVA) Presents at Oppenheimer 36th Annual Healthcare Life Sciences Conference Transcript
IXJ: Healthcare Sector Dashboard For February
MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies